GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.837
+0.114 (15.77%)
At close: Apr 28, 2026, 4:00 PM EDT
0.860
+0.023 (2.75%)
After-hours: Apr 28, 2026, 7:59 PM EDT
GlucoTrack Employees
GlucoTrack had 11 employees as of December 31, 2024. The number of employees increased by 5 or 83.33% compared to the previous year.
Employees
11
Change (1Y)
5
Growth (1Y)
83.33%
Revenue / Employee
n/a
Profits / Employee
-$1,762,545
Market Cap
1.63M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 227 |
| Bionano Genomics | 97 |
| Femasys | 54 |
| Nephros | 36 |
| NEXGEL | 19 |
| Milestone Scientific | 15 |
GCTK News
- 7 days ago - Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology - GlobeNewsWire
- 4 weeks ago - Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 4 weeks ago - Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones - GlobeNewsWire
- 6 weeks ago - GlucoTrack Transcript: EGM 2026 - Transcripts
- 7 weeks ago - Glucotrack to Present at LSI USA '26 Medtech Innovation Summit - GlobeNewsWire
- 3 months ago - Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform - GlobeNewsWire
- 4 months ago - Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor - GlobeNewsWire
- 5 months ago - Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights - GlobeNewsWire